Goodricke standalone Q1 PAT swings to ₹40.9 Cr as 41% crop recovery lifts OPM to 17.9%

Goodricke Group's standalone Q1 FY27 (quarter ended 30 June 2026) revenue rose 21.1% YoY to ₹211.30 Cr from ₹174.51 Cr, and the company swung to a net profit of ₹40.87 Cr (EPS ₹18.92) against a thin ₹3.19 Cr profit (EPS ₹1.48) a year earlier — nominally a >12x jump, but almost entirely a base effect since Q1 FY26 profit was near-breakeven. PAT includes a ₹5.80 Cr exceptional gain on the sale of specified assets and leasehold rights at a tea estate (₹19.00 Cr consideration, board-approved 3 April 2026, transacted May 2026); stripping this out, PBT before exceptional was ₹37.35 Cr and adjusted PAT is roughly ₹35.4 Cr — still up sharply YoY, but the triple-digit percentage move is a function of the tiny year-ago base rather than a repeatable growth rate. Sequentially, revenue more than doubled (+103.5% QoQ) and PAT reversed a ₹29.21 Cr Q4 FY26 loss (EPS -₹13.52); this QoQ swing is a seasonality artifact typical of the tea business — Q4 (Jan-Mar) is the lean off-season with heavy fixed-cost drag, while Q1 picks up with the new crop — and should not be read as sequential momentum.

Margins expanded materially on both bases: net margin was 18.94% versus -27.86% last quarter and 1.77% a year ago, and OPM (EBITDA/revenue) was 17.90% versus -23.65% QoQ and 1.67% YoY. Management's own note in the filing attributes the improvement to the company's own tea crop volume being 41% higher than the year-ago period (excluding the estate sold) combined with better price realisations and a cost/quality focus — this framing is directly consistent with both the revenue growth and the margin expansion this quarter. Total expenses were roughly flat YoY (₹178.50 Cr vs ₹178.39 Cr) even as employee costs rose to ₹99.14 Cr from ₹95.86 Cr, indicating the margin gain came from operating leverage on higher volumes/realisations rather than cost cutting.

The stock went into the print at ₹191, up 3.8% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters.

There is no prior management guidance or concall commentary on record for this stock, and no broker/consensus estimates could be located (Goodricke is a micro-cap, ~₹407 Cr market cap, with negligible analyst coverage) — so this print cannot be benchmarked against a street number or a prior outlook; both are being reported as unknown/none rather than assumed. Separately, the auditor's qualification that applied a year ago recurs this quarter: the statutory auditor (MSKA & Associates, newly reappointed for a five-year term from 4 August 2026) issued a qualified review conclusion because the company values quarterly tea stock at estimated full-year production/cost rather than actual cost for the quarter — a methodology caveat rather than a restated number, but one that limits comparability of the quarterly P&L construct itself. The board also approved Grant Thornton Bharat LLP as internal auditor for FY27-FY29 at the same meeting, unrelated to the P&L print.